Halozyme

HALO · NASDAQ🇺🇸

Overview

Earnings Dividends Seasonality Metrics

Reported earnings about 1 month ago

Amortization of intangibles

$23.4M

Previous year: $17.8M

Loading...

Halozyme

Unlock previous datapoints

Upgrade

Halozyme

Unlock previous datapoints

Upgrade

Halozyme Revenue by Segment

Revenue by Segment

Royalties Revenue

Unlock previous datapoints

Upgrade

CapyFin.com

Product sales, net Revenue

CapyFin.com

Revenues under collaborative agreements Revenue

Unlock previous datapoints

Upgrade

CapyFin.com

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$7.32B

P/E Ratio

15.31

Sector

N/A

Industry

N/A

52-Week High

$80.5

52-Week Low

$47.9

Adjusted EBITDA

$21.9M

EBITDA

-$71.7M

Amortization of intangibles

$23.4M

Research and development expense

$31.9M

Selling, general and administrative expense

$77M

Products

Get in Touch

Resources

Halozyme

Halozyme

Halozyme

Halozyme Revenue by Segment

Revenue by Segment

Royalties Revenue

Product sales, net Revenue

Revenues under collaborative agreements Revenue

Historical Earnings Impact

Avg. Return Before/After Earnings

Key Statistics